The Effect of Enamel Matrix Derivative/Papilla Reflection Surgery on the Clinical and Alveolar Bone Outcomes in Periodontal Maintenance Patients by Jasa, Erica E
University of Nebraska Medical Center 
DigitalCommons@UNMC 
Theses & Dissertations Graduate Studies 
Spring 5-4-2019 
The Effect of Enamel Matrix Derivative/Papilla Reflection Surgery 
on the Clinical and Alveolar Bone Outcomes in Periodontal 
Maintenance Patients 
Erica E. Jasa 
University of Nebraska Medical Center 
Follow this and additional works at: https://digitalcommons.unmc.edu/etd 
 Part of the Periodontics and Periodontology Commons 
Recommended Citation 
Jasa, Erica E., "The Effect of Enamel Matrix Derivative/Papilla Reflection Surgery on the Clinical and 
Alveolar Bone Outcomes in Periodontal Maintenance Patients" (2019). Theses & Dissertations. 369. 
https://digitalcommons.unmc.edu/etd/369 
This Thesis is brought to you for free and open access by the Graduate Studies at DigitalCommons@UNMC. It has 
been accepted for inclusion in Theses & Dissertations by an authorized administrator of DigitalCommons@UNMC. 
For more information, please contact digitalcommons@unmc.edu. 
   
THE EFFECT OF ENAMEL MATRIX DERVIATIVE/PAPILLA REFLECTION SURGERY ON THE CLINICAL 
AND ALVEOLAR BONE OUTCOMES IN PERIODONTAL MAINTENANCE PATIENTS 
 
by 




Presented to the Faculty of 
the University of Nebraska Graduate College 
in Partial Fulfillment of the Requirements 
for the Degree of Master of Science 
 
Medical Sciences Interdepartmental Area 
Oral Biology 
 
Under the Supervision of Professor Richard A. Reinhardt 
 






Amy C. Killeen, D.D.S., M.S. 
Jeffrey B. Payne, D.D.S., M.S. 
James K. Wahl III, Ph.D. 
Sung K. Kim, D.D.S. 
 
  
  i 
ACKNOWLEDGEMENTS  
As I look back on the past three years of my periodontal residency, I am reminded of the 
support, hard work, and dedication it took to get me to this point.  I knew making the decision 
to get my Masters of Science in Oral Biology was going to challenge me in multiple ways I hadn’t 
experienced in my academic journey thus far.  I knew it would require a time commitment and 
would take me out of my comfort zone, all while increasing my knowledge of my area of 
specialty and allowing me to contribute to research in the field of periodontics. 
I would like to thank Dr. Richard Reinhardt, my advisor, for his mentorship.  He was 
always willing to sit down and discuss my research project, even if this meant explaining things 
multiple times until I fully understood.  His extraordinary knowledge and patient teaching 
abilities allowed me to grow as a student, researcher, and periodontist. I was honored to have 
the opportunity to work with and learn from one of the most well-respected experts in the field 
of periodontics.  His guidance was crucial to the success of my study. 
I would also like to thank Dr. Amy Killeen, who dedicated many hours of her time to 
organize and successfully implement the study.  Her incredible knowledge of periodontics and 
research was vital to the acceptance of the study.  Dr. Killeen always found ways to help me 
work through problems I encountered along the way, and she was the best at suggesting ways 
to relieve the stress that comes along with the challenges of residency.  Whether she suggested 
a coffee/chocolate break, a yoga class to burn off any frustration, or just a minute to sit and chat 
in her office, her advice always proved to be helpful and allowed me to visualize the big picture.  
Her expertise, encouragement, and support were some of the reasons I embraced the field of 
periodontics, and I am thankful to have had the privilege of working with her.  
  ii 
 
My co-resident, Dr. Jessica Gradoville, and I collaborated and worked well together 
throughout our experiences and studies.  Her thoughtfulness, encouragement, and sense of 
humor made the challenges of residency seem like just another day spent with my best friend.  I 
can’t imagine going through residency without her by my side.  I am so thankful for our 
friendship.  
Additionally, I need to acknowledge the following members of my research 
committee:  Dr. Jeffrey Payne, for sharing his enthusiasm of periodontics with me, his hands on 
contribution to the study, and for always holding me to the highest of standards because he 
knew what I was capable of.  Dr. Sung Kim and Dr. Jim Wahl for their thoughtful insight and 
advice on the study protocol.  Kaeli Sampson for her expertise in statistics and data analysis.  
Mrs. Megan Christiansen for successfully recruiting and scheduling patients, and performing 
each and every periodontal maintenance procedure.  The study could not have been completed 
without her immense time commitment, organization, and thorough care for the patients. 
I would also like to recognize the patients who participated in this study for dedicating 
their time and contributing to the advancement of the field of periodontics.  Thank you to 
Windsweep Farm and the late Dr. Mick Dragoo and his wife Mary, for their generous 
contributions and funding of this research.  Thank you to UNMC College of Dentistry 
Department of Periodontics for the support and use of the facility. 
A special thanks to Taylor Steger, for his patience, faith, and confidence in me, as I 
worked to accomplish my goals.  Finally, I would like to thank my parents, Rod and Hannelore 
Jasa, for their unwavering love, support, and encouragement as I pursued my dreams. 
   
THE EFFECT OF ENAMEL MATRIX DERIVATIVE/PAPILLA REFLECTION SURGERY ON THE CLINICAL 
AND ALVEOLAR BONE OUTCOMES IN PERIODONTAL MAINTENANCE PATIENTS 
 
Erica E. Jasa, D.D.S., M.S. 
University of Nebraska, 2019 
Advisor: Richard A. Reinhardt, D.D.S., Ph.D. 
The purpose of this study was to determine if local application of enamel matrix 
derivative (Emdogain; EMD), combined with minimally invasive papilla reflection/root 
preparation (PR/RP), is effective in improving probe depth (PD), clinical attachment level (CAL), 
and interproximal bone height (IBH) in persistent 6-9 mm periodontal pockets in patients on 
periodontal maintenance therapy (PMT).  Fifty periodontal maintenance patients with advanced 
chronic periodontitis presenting with a 6-9 mm interproximal PD were included in study. 
Experimental (PR/RP+EMD; n=24) and control (PR/RP+S; n=26) therapies were randomly 
allocated. Roots were treated with reflection of interproximal papillae, root planing assisted 
with endoscope evaluation, and acid etching, followed by EMD or saline application. Clinical 
measurements were collected at baseline, six months, and 12 months post-therapy.  IBH 
measurements were made on standardized vertical bitewing radiographs taken at baseline and 
12 months.  Both PR/RP+EMD and PR/RP+S resulted in significant improvements in clinical 
outcomes (PD: -2.3 ± 0.2 mm, -2.4 ± 0.2 mm, p<0.0001; CAL: -1.8 ± 0.3 mm, -2.2 ± 0.3mm, 
p,0.0001) and stable IBH (-0.2 ± 0.18 mm, -0.33 ± 0.18 mm, p>0.05), from baseline to 12 
months. No significant differences were found in clinical outcomes between the experimental 
group and the control.  The addition of EMD to PR/RP does not significantly improve clinical 
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CHAPTER 1:  INTRODUCTION 
     Periodontitis is an inflammatory disease which affects the hard and soft tissue 
attachment and supporting structures of the dentition (AAP Parameters of Care, 2000), affecting 
approximately 42% of the population in adults 30 years of age or older in the United States (Eke 
et al., 2018). The prevalence and severity of periodontitis increases with age and has a higher 
occurrence rate in males (Eke et al., 2015). 
    Diagnosis of periodontitis is made based on clinical parameters including: presence or 
absence of bleeding on probing (BOP), severity of bone loss and attachment loss, periodontal 
pocketing, extent and pattern of teeth involved, medical and dental risk factors, pain, ulceration, 
and amount of plaque (PL) and calculus present (AAP Position Paper, 2003).  The type and 
severity of periodontitis (chronic vs. aggressive, localized vs. generalized, or periodontitis as a 
manifestation of systemic disease) must be accurately differentiated from other similar 
diagnoses to allow for and ensure proper treatment protocol (Armitage, 1999). 
    Treatment of periodontitis via the removal of bacterial biofilm, calculus, and toxic 
cementum through scaling and root planing (SRP) is considered the “gold standard” (Cobb, 
2002) and has been successful in showing improvements in clinical parameters and a reduction 
of inflammation (Kaldahl et al., 1996a, Becker et al., 2001).  Periodontal pockets that continue to 
have BOP and/or an increasing probing depth (PD) are indicative of continued inflammation 
(Amato et al., 1986), and the presence of bacteria (Wilson et al., 2008), and are at risk of further 
breakdown and disease progression (Renvert et al., 2002). These non-responding sites may 





Once a patient has been determined to be stable, the patient is placed into a 
periodontal maintenance therapy (PMT) program consisting of dental visits every three-four 
months where he/she receives continued periodontal evaluation and monitoring, biofilm and 
root surface decontamination, and oral hygiene instructions (OHI).  Participation in PMT is 
critical to the long-term success of periodontal treatment (Nyman et al.. 1975; Nyman et al., 
1977; Becker et al,. 1984a; Becker et al., 1984b; Wilson et al., 1987). 
    When treating periodontitis during PMT, not all patients remain stable with conventional 
treatment modalities.  For instance, isolated deep interproximal pockets (6-9 mm) commonly 
develop. Therefore, adjunctive therapies have been developed and added to traditional 
periodontal therapies.  These adjuncts include systemic antibiotics (Sgolastra et al., 2014), local 
delivery of antibiotics (Kinane & Radvar, 1999), subgingival irrigation (Jolkovshy et al., 1990), 
lasers (Cobb, 2006), and varying biologics and growth factors (Mobelli, 2005).  These adjunctive 
therapies aim to decrease the bacterial load, aid in reduction of inflammation, and stimulate 
new attachment to the root or bone growth. Outcomes to these approaches during PMT are 
rarely reported and are often suboptimal (AAP, 2006).  Additionally, conventional periodontal 
surgery carries morbidity that is often unacceptable to the patient.  Less invasive approaches 
with local application of drugs known to stimulate periodontal regeneration would add a 
valuable option for retreatment.   
The use of enamel matrix derivative, or Emdogain (EMD), as an adjunct to periodontal 
therapy is proposed for regeneration of lost periodontal structures (Hammarstrom et al., 1997; 
Sculean et al., 1999).  The use of EMD has most often been studied in conjunction with surgical 




al., 1997; Froum et al., 2001, Sculean et al., 2001; Sanz et al., 2004).  Although little impact was 
noted when adding sulcular EMD following SRP (Gutierrez et al., 2003; Mombelli et al., 2005), 
simple papilla reflection has not been tested to allow enhanced root preparation and EMD 
application during PMT.  Much of the data surrounding the use of EMD are conflicting or has 
been funded by the company which produces EMD.  Evidence of the use of EMD in periodontal 
maintenance patients is lacking, and, therefore, further research is indicated in the use of EMD 
in this patient population. 
The hypothesis of the current study is that interproximal papilla reflection, root 
preparation (root planing) with fiberoptic visualization and etching, with or without EMD 
application as the variable, will reduce probing depth, clinical attachment loss, and improve 




CHAPTER 2:  LITERATURE REVIEW:  PERIODONTITIS 
Periodontitis is an inflammatory disease affecting the supporting structures of the 
dentition.  Periodontitis presents as inflammation of the gingiva and periodontal ligament (PDL), 
causing damage to alveolar bone and cementum.  The disease can clinically manifest itself as 
gingival erythema with an increase in PD, loss of clinical attachment level (CAL), tooth mobility, 
BOP, suppuration, abscess formation, gingival recession (REC), and discomfort.  If left untreated, 
it may result in further loss of attachment and eventual tooth loss (AAP Position Paper, 1999). 
Periodontitis is a complex and multifactorial disease process consisting of interactions 
between pathogens and the host’s response to them (Preshaw, 2008).  The main etiologic cause 
of periodontal disease has been attributed to bacterial plaque and calculus (Socransky & 
Haffajee, 1992). However, bacteria alone may not be enough to account for the progression of 
the disease.  Host susceptibility has been found to be a vital part of the disease progression. 
Over 500 microorganisms have been identified in periodontal disease, but it is thought that only 
10-20 of these may play a part in the pathologic etiology of the disease (Moore, WE. & Moore, 
LV., 1994).  Many factors may allow for a progression of disease. Periodontitis may occur when 
the pathogen is of a virulent type and possesses genetic factors to initiate disease, the host is 
susceptible to the pathogen, the pathogen is present in number sufficient to exceed the 
threshold of the host, other bacterial species do not alter the progress of the disease, and the 
local environment is conducive to the pathogens’ virulence properties (Socransky & Haffajee, 
1992).  Certain genetic factors have also been suggested as contributors to various forms of 
periodontitis, including neutrophil dysfunction (Van Dyke et al,. 1985) and IL-1 polymorphism 




The goal of treating periodontal disease is to halt the progression of periodontal 
destruction by reducing inflammation and restoring the patient to a comfortable and functional 
dentition (Zander et al., 1976).  Treatment can be achieved by non-surgical therapy, surgical 
therapy, or a combination of both. These treatments allow for a disruption of the bacteria, 
detoxification of the root surface, and a reduction in the microbial load, thereby reducing 
inflammation in the pocket and allowing for the host to compensate.  Clinical improvement is 
measured using change in PD, presence of BOP, plaque index, and gain in CAL (Haffajee et al., 
1997). 
Non-surgical periodontal therapy, or SRP, has been coined the “gold standard” of 
periodontal treatment (Cobb, 2002).  This consists of the removal of bacterial plaque and 
calculus by instrumentation of the crown and root with hand instruments and/or ultrasonic 
instruments.  Removal of the plaque and calculus results in a reduction of the bacterial load 
(Socransky et al., 2013) and detoxification of the root (Nishimine & O’Leary, 1979).  Many 
studies have demonstrated improvements in periodontal health and clinical parameters 
following SRP (Kaldahl et al., 1996a; Becker et al,. 2001; Mialoa et al., 2015). 
If signs of disease activity, such as an increase in PD, BOP, and continued attachment 
loss, persist following mechanical therapy, other therapies including surgical intervention, 
and/or the use of adjunctive pharmacotherapeutic and biomaterials may be 
considered.  Additional risk factors which may be contributing to the disease process also need 
to be identified such as occlusal trauma, iatrogenic restorations, malocclusion and crowding, 




residual signs of inflammation and deep PD are more likely to progress and experience 
recurrence of disease (Claffey et al., 1990; Renvert & Persson, 2002; Matuliene et al., 2010). 
Once a patient’s periodontal status is determined to be stable, he/she will enter into 
periodontal maintenance and will be monitored for changes in the periodontium during more 
frequent dental visits and cleanings, usually every three-four months.  The goals of PMT are: 1) 
to prevent or minimize the recurrence of disease progression; 2) prevention or reduction of the 
incidence of tooth loss; and 3) to increase the probability of locating and treating other 
conditions or diseases found within the oral cavity in a timely manner (Cohen, 2003).  PMT helps 
to maintain periodontal health by decreasing etiology and stabilizing the attachment. At each 
PMT visit, an evaluation of the patient’s periodontal status is performed by the collection of 
clinical measurements. Removal of supragingival and subgingival bacterial plaque and calculus is 
then performed, along with a review and reinforcement of oral hygiene instructions, and a 
determination of any additional needed treatment (Cohen, 2003). 
Studies have shown that patients undergoing regular PMT have less incidence of 
periodontal breakdown and keep their teeth longer than those who are erratic or non-compliers 
(Wilson, 1987).  Regular maintenance therapy along with proper oral hygiene may resolve 
gingivitis and help prevent loss of periodontal tissue support (Axelsson et al., 1991).  Patients 
who receive periodontal therapy and do not follow through with maintenance, do not see long 
term improvements in PD and bone levels.  In these patients, the improvements seen following 
periodontal therapy are ultimately lost, and they eventually return to a diseased state (Becker, 
1984a; Becker, 1984b; Alexelsson & Lindhe, 1981). Therefore, participation in a periodontal 










CHAPTER 3:  LITERATURE REVIEW:  ENDOSCOPE AND MINI-FLAP 
The primary objective of periodontal treatment is to remove the plaque biofilm, 
calculus, and contaminated root surface, thereby lowering the threshold of bacteria (Cobb, 
1996).  However, restricted access in deep pockets can create challenges making non-surgical 
treatment difficult.  Studies have shown that there is a threshold of severity at which 
instrumentation becomes less effective.  Curette efficacy ranges from 2-4 mm, with calculus free 
surfaces only being found up to 3.73 mm (Stambaugh, 1981).  As the pocket depth increases, 
there is a higher correlation of percent of residual calculus present (Rabbani et al., 1981).   
The detection of subgingival calculus is not a precise action.  Calculus detection is most 
often done with the light tactile touch of an explorer, relying on the clinician’s opinion on 
whether or not calculus is present.  This can also lead to inconsistencies between clinicians, as 
there are differences in what a clinician determines a smooth root surface to be.  Studies 
evaluating the accuracy of subgingival calculus detection have shown 75% accuracy in the 
clinician’s ability to determine the presence of calculus, and a 50% accuracy in the clinician’s 
ability to determine the surface free of calculus (Sherman et al., 1990).  The microscopic 
presence of calculus was always found to be greater than the clinical detection (Sherman et al., 
1990).  
The effectiveness of instrumentation can also be affected by tooth anatomy or position 
in the arch.  Interproximal surfaces were found to have residual calculus more frequently than 
the facial and lingual surfaces, both microscopically and clinically (Sherman et al., 1990).  Molars 
have been shown to have more residual calculus than non-molar sites (Sherman et al., 1990). 




concavities add to the complexity (Fleischer et al., 1989).  In deeper pockets, in order to ensure 
more calculus removal and better access to the depth of the pocket, adjunct procedures may 
need to be combined with non-surgical therapy.  
Endoscope 
The precise detection of subgingival calculus and the evaluation of the root surface and 
soft tissue is critical for diagnosing and treatment planning during periodontal therapy, if 
successful outcomes are desired (Stambaugh et al., 2002).  The use of a dental endoscope can 
aid in subgingival visualization of the root surface and calculus detection. The dental endoscope 
uses a thin fiber-optic cord inserted into a sheath with a light source to illuminate the root 
surface. The sheath also provides constant water flow to clear the visual field of biofilm, 
calculus, blood, and other debris.  The images are magnified and transmitted back to a display 
screen for visualization in real time.  The endoscope can be used in conjunction with ultrasonic 
and hand instruments, which may allow the clinician to achieve better clinical results.  In a 
systematic review, it was determined that the use of a periodontal endoscope may provide an 
additional benefit of calculus removal compared to SRP alone, but no significant differences 
were found in clinical parameters with respect to BOP, gingival index, and PD with the aid of the 
endoscope compared to SRP alone (Kuang et al., 2017).  The percentages of residual calculus 
present after periodontal therapy performed with the aid of the endoscope were significantly 
less than the amount present following SRP; however, SRP with the endoscope required 
significantly more time for debridement than SRP alone (Kuang et al., 2017). Some studies 
reported greater reductions in gingival index and BOP with the use of the endoscope (Wilson et 




clinicians in the ability to visualize periodontal conditions, and, therefore, may improve calculus 
detection (Stambaugh et al., 2002).  
Minimally Invasive Surgical Techniques 
In deep periodontal pockets which do not respond to non-surgical therapy, surgical 
access has been shown to aid in calculus removal, especially in furcation areas or deep pockets 
where closed instrumentation is difficult (Fleischer et al., 1989).  However, periodontal surgery 
increases morbidity, chances for infection, and postoperative pain for the patient.  Minimally 
invasive non-surgical periodontal therapy provides another alternative to traditional surgical 
periodontal therapy, in order to achieve subgingival debridement with minimal tissue 
trauma.  Minimally invasive procedures consist of localized papilla reflection to allow access to 
an area of localized periodontal destruction and usually involve the use of magnification with 
either loupes or microscopes.  Minimally invasive procedures look to minimize patient 
postoperative discomfort and maximize the healing potential (Cortellini & Tonetti, 
2007).   Microsurgery can result in limited soft tissue damage, limited recession, gains in 
attachment, improvement of soft tissue healing, and a high probability of primary closure 
(Cortellini et al., 2001).  Improvements can also be seen in the rate of healing, reduction of 
postoperative pain, and improved retention of soft tissue height and contour (Harrel, 
1999).  Minimally invasive procedures may promote an enhanced clinical improvement in 
intrabony defects, including larger reductions in probe depths, and gain in clinical attachment 
level and radiographic bone height compared to non-surgical therapy (Nibali et al., 2015). Sites 
with interdental papilla reflection also exhibited less residual calculus compared to sites without 




minimally invasive techniques compared to larger surgical flaps (Cortellini & Tonetti, 2009). 
Improvements seen following a minimally invasive approach appear to heal similarly to single 
flap surgeries (Trombelli et al., 2007) and appear to be stable long term (Nibali et al., 2018). 
Combination of the minimally invasive approach with visualization provided by the 
periodontal endoscope may allow for enhanced clinical improvements in localized areas of 
periodontal inflammation.  The combination of these two procedures allows the clinician to gain 
better access in deep periodontal pockets resulting in more calculus removal, while minimizing 
trauma and maximizing the healing potential for the patient. 
When local application of periodontal regenerative drugs and root etching are proposed 





CHAPTER 4:  LITERATURE REVIEW:  EMDOGAIN 
The aim of periodontal treatment is to halt the progression of periodontal attachment 
loss and establish a dentition that is functional and comfortable for the patient (Zander et al., 
1976).  Periodontal treatment may also consist of procedures designed to regenerate lost 
periodontal tissues (Philstrom & Ammons, 1997).  Many regenerative procedures have been 
investigated and have shown success, including root conditioning, grafting with various 
materials (autografts, allografts, xenografts), and the use of barrier membranes.  More recently, 
the use of biologics and growth factors have been added to the repertoire to aide with 
periodontal regeneration procedures.  One which has shown particular success is enamel matrix 
derivative, or Emodgain (EMD).  EMD is an extract of embryonic enamel matrix from six month 
old piglets, and it is thought to induce mesenchymal cells to mimic the process of the 
development of the root and periodontal tissues (Venzia et al., 2004).  EMD is mostly composed 
of amelogenins which are involved in the formation of enamel and development of acellular 
cementum (Brookes et al., 1995).  Cementum deposition aides in the development of the 
periodontal attachment apparatus and is required for the formation of both the periodontal 
ligament and alveolar bone (Armitage, 1991).  Deposition of enamel matrix proteins onto a 
dentin surface initiates the cementogenesis process.  Once cementum has been laid down onto 
an enamel-matrix covered dentin surface, the attachment apparatus can develop (Slavkin et al., 
1989; Lindskog & Hammarström et al., 1982).  
EMD appears to enhance proliferation of PDL cells, but not epithelial cells, thus allowing 
for regeneration of the periodontal tissues (Gestrelius et al., 1997).  EMD has also been shown 




proliferation, and metabolism of human PDL cells (Lyngstadaas et al., 2001).  EMD adsorbs to 
hydroxyapatite and collagen on denuded roots forming insoluble complexes which can remain 
detectable for up to two weeks.  This time frame appears to be sufficient to allow for 
recolonization of the periodontal ligament cells (Gestrelius et al., 1997).  In vitro studies have 
demonstrated EMD’s ability to limit epithelial downgrowth on the root surface, which may be 
similar to that seen by the mechanical prevention achieved with barrier membranes 
(Hammarström, 1997; Venzia et al., 2004).  
Surgical Periodontal Therapy + EMD 
Clinical trials evaluating the use of EMD have most often been done evaluating EMD in 
conjunction with surgical procedures in intrabony periodontal defects.  In a split mouth study, 
EMD as an adjunct to Modified Widman Flap (MWF) surgery for treatment of intrabony defects, 
showed a greater gain in CAL, reduction in PD, and increased gain of radiographic bone fill 
(66%), compared to MWF plus a placebo (Heijl et al., 1997).  Additional studies compared the 
use of EMD to a placebo, with open-flap debridement (OFD), and found similar results in clinical 
and radiographic outcomes between the two (Zetterstrom et al., 1997; Pontoriero et al., 1999). 
A meta-analysis reviewed the studies comparing EMD to OFD and found the EMD groups had 
significantly higher reductions in PD (4.82 ± 0.02 mm vs. 2.59 ± 0.06 mm, p = 0.000) and gains 
CAL (4.07 ± 0.03 mm vs. 2.55 ± 0.04 mm, p = 0.000); no significant differences were seen in the 
initial PD and CAL between groups (Venzia et al., 2004).  In contrast, one clinical trial failed to 
demonstrate an advantage with the use of EMD in infrabony defects during OFD compared to 





EMD vs GTR 
The gold standard of regenerative procedures is guided tissue regeneration (GTR) with 
the use of barrier membranes.  Studies comparing the regenerative effects of EMD to those of 
GTR have shown promising results in EMD’s regenerative capabilities.  The studies show both 
the use of EMD and GTR lead to comparable improvements in regards to CAL gains and osseous 
defect fill compared to OFD alone (Kalpids & Ruben, 2003).  No significant differences were seen 
in probing depth reduction between EMD and GTR, with both groups showing an improvement 
from baseline (Sculean et al., 1999; Pontoriero et al., 1999; Minabe et al., 2002; Venzia et al., 
2004).  However, GTR has been shown to have more surgical complications compared to EMD, 
mainly due to membrane exposure, illustrating EMD’s clinical advantage in sites where 
membrane placement may be difficult (Sanz et al., 2004). 
Non-surgical Periodontal Therapy + EMD 
Clinical outcomes following non-surgical therapy with the addition of EMD have not 
been studied as extensively.  Only two clinical studies have been done evaluating these results. 
Both studies failed to show any clinical benefits to the use of EMD as an adjunct to non-surgical 
treatment (Gutierrez et al., 2003; Mombelli et al., 2005).  This may be because horizontal 
defects are less likely to exhibit success following regenerative procedures (WIkesjo & Selvig, 
1999) and EMD was not allowed contact with deeper connective tissue and bone.  It is, 
therefore, recommended that EMD be used in conjunction with surgical therapy to fully reap 






EMD + Minimally Invasive Surgical Techniques 
    The aim of minimally invasive surgical techniques (MIST) is to reduce the postoperative 
morbidity associated surgical procedures and allow for improved healing.  Few studies have 
investigated the use of EMD with MIST. In studies utilizing MIST with the addition of EMD, 
improvements were seen in CAL, PD, initial would stability, and defect resolution with limited 
patient morbidity (Cortellini & Tonetti, 2007; Cortellini & Tonetti, 2009).  In another controlled 
clinical study, the use of EMD did not provide superior benefits on the outcome of the MIST 
procedure, as both groups reported significant PD reductions, CAL gains, and radiographic bone 
fill at three and six months (Ribeiro et al., 2011).  
Conflicting and limited data on the use of EMD for the treatment of periodontal defects 





MATERIALS AND METHODS  
Study Population and Research Design 
This 12 month, randomized, double-masked, parallel interventional, clinical trial 
included randomization of 50 individuals (26 males, 24 females) who were receiving periodontal 
maintenance therapy at the University of Nebraska Medical Center (UNMC) College of Dentistry. 
The study protocol flow chart is presented in Figure 1.  Inclusion criteria were as follows: 1) 40-
85 years old; 2) a diagnosis of advanced chronic periodontitis (majority of patients were Stage 
III, Grade B; AAP, 2018); 3) with at least one 6-9 mm interproximal periodontal probing depth 
with a history of bleeding on probing; 4) overall good systemic health; 5) history of regular 
periodontal maintenance therapy; and 6) willingness to sign consent form. Exclusion criteria 
were as follows: 1) systemic diseases which significantly impact periodontal inflammation and 
bone turnover (e.g., chronic use of steroids or non-steroidal anti-inflammatory drugs (>325 
mg/d), estrogens, bisphosphonates, calcitonin, methotrexate, antibiotics); 2) surgical 
periodontal therapy within the past year; 3) interproximal defects with vertical component of >3 
mm; 4) pregnant or breast-feeding females.  The protocol was approved by the UNMC 
Institutional Review Board, Omaha, Nebraska (protocol #783-16-FB) and was conducted in 
accordance with the Declaration of Helsinki of 1975, as revised in 2013.  Recruitment for the 
study took place from September 2016 to April 2017.  The study was conducted from February 








UNMC periodontal maintenance patients were screened, and those meeting the 
inclusion criteria were invited to participate and given written informed consent.  
Randomization was stratified by gender and smoking status, via a preset randomization table. 
The experimental site of the individuals was assigned from screening data (6-9 mm periodontal 
probe depth with history of BOP).  The test group received papilla reflection and root planning 
(PR/RP), with visual augmentation using an endoscope, and root etching with 
ethylenediaminetetraacetic acid (EDTA) for two minutes, and Emdogain (PR/RP + EMD) injected 
into the open interproximal site, whereas the control group received PR/RP, and root etching 
with saline (PR/RP + S), in one experimental site per individual. 
Sample Collection and Clinical Measurements  
One of three calibrated examiners (AK, RR, JP), without knowledge of experimental 
group assignment, isolated the experimental site with cotton rolls.  Supragingival plaque (PL) 
was removed (and recorded) with curettes, and the site was gently dried with an air syringe. A 
periodontal paper strip (Periopaper, Proflow, Amityville, NY) was inserted into the experimental 
interproximal site sulcus on both buccal and lingual until mild resistance was felt, and was left 
for 30 seconds to collect gingival crevicular fluid (GCF).  Next, gingival recession and probing 
depths were recorded with a UNC 15 probe on the experimental tooth and adjacent tooth at 
mesial-facial, mid-facial, distal-facial, mesial-lingual, mid-lingual, and distal-lingual by the same 





Interproximal bone height (IBH) measurements were made on vertical bitewings made 
with a modified positioning indicating device (PID) aligner (Figure 2).  Measurements were made 
from the cementoenamel junction (CEJ) to the most coronal aspect of the alveolar crest, where 
the periodontal ligament space was uniform.  If a restoration was present on the tooth surface 
being measured, measurements were taken from the apical margin of the restoration to the 
most coronal aspect of the alveolar crest.  IBH measurements were made at the treatment site, 
as well as the interproximal of the adjacent tooth (Figure 3).  Interproximal vertical defects of 
>3mm were used an exclusion criteria for study participation. 
Treatment 
One of two periodontal residents (EJ, JG), performed the experimental site treatment.  A 
baseline vertical bitewing radiograph was made with a modified PID aligner to standardize 
radiography beam geometry.  Local anesthetic was administered to the experimental site. 
Surgical reflection of the buccal and lingual/palatal papillae, localized to the experimental site, 
was done using #12b blade and Molt #2 elevator.  Granulation tissue and remaining 
interproximal soft tissue was removed using scalers (Hu-Friedy, Chicago, IL) and an ultrasonic 
scaling system (Cavitron, Dentsply, York, PA) was used to allow access to the root and 
visualization to within 2 mm of the bone. Scaling and root planing of experimental and adjacent 
interproximal teeth were performed to remove supra- and subgingival bacterial plaque and 
calculus.  Circumferential cleaning was done to prevent any disturbances to the re-
approximated papilla during the subsequent periodontal maintenance appointment. Verification 




optic visualization with an endoscope (Perioscope, Zest Dental Solutions, San Ramon, CA).  If the 
root surface was not adequately prepared, then scaling and root planing was repeated and 
verified until satisfactory.  The root surface and papilla were irrigated with sterile saline to 
remove any debris from the pocket.  The root surface was etched for two minutes with EDTA 
(Pref-Gel, Straumann, Andover, MA), to further detoxify the root surface, followed by irrigation 
with sterile saline. Depending on randomization, either 0.3 ml hydrophobic enamel matrix 
protein (Emdogain, Straumann, Andover, MA) or 0.3 ml sterile saline was placed to the bone 
and PDL, and deposited up the root surface of the experimental and adjacent interproximal 
tooth.  Any excess was removed and using a damp gauze and compression.  The buccal and 
lingual/palatal papilla were re-approximated.  Damp gauze pressure was applied for three-five 
minutes followed by application of intraoral cyanoacrylate (Periacryl, GluStitch Inc., Delta, BC, 
Canada) to stabilize clot formation and secure the papilla.  Routine periodontal maintenance, 
including full-mouth debridement and root planing of inflamed pockets (excluding experimental 
site), was then performed by a registered dental hygienist (MC).  Patients were instructed to 
avoid brushing and interproximal cleaning of the experimental site for six weeks, per the 
Straumann Emdogain protocol.  Patients were provided a bottle of Listerine mouthrinse 
(Johnson & Johnson, New Brunswick, NJ), to rinse with two times per day for the six week 
postoperative period. 
Patients were asked to return for postoperative visits at two and six weeks along with 
periodontal maintenance recalls at three, six, nine, and 12 months. GCF collection was repeated 
at two weeks, six months, and 12 months. The same measurements completed at baseline were 




maintenance therapies.  Participants were questioned about adverse events at two weeks, six 


















Figure 2:  Radiographic Modified PID Aligner 
 
Left: Non-modified PID aligner Right: Modified PID aligner (used in this study) 
 
 






Figure 3:  Radiographic Bone Height Measurements  
Initial Radiograph           
 
12 month Post-Op Radiograph  




Figure 4:  Clinical Photos of Surgical Procedure  
Baseline PD Measurement 
 


















Statistical analyses:  
For patients to be enrolled in this study, they must have had a probing depth of at least 
6 mm on either the buccal or lingual of the interproximal site.  For purposes of analyses for PD 
and CAL, only the measurement from the site with the deepest probing depth on the treatment 
tooth was analyzed, if both sides had equally deep probing depths, then treatment site 
measurements were averaged across the buccal and lingual.   
For IBH and treatment site PL measurements, both buccal and lingual sites were 
assessed, regardless of the site of deepest probing depth.  PL was considered present at baseline 
if at least one site (buccal or lingual) had the condition present.  Differences in the proportion of 
patients with PL at baseline vs. twelve months was assessed using McNemar’s tests, separately 
for Emdogain and saline patients.    
Means were computed across buccal and lingual sites for each measurement.   For each 
variable, a new variable indicating change was calculated by subtracting the baseline values 
from the 12 month values.  Differences between treatment (EMD or saline) at baseline, 12 
months, or the change from baseline to 12 months were assessed using Wilcoxon Rank Sum test 
or T-test.  Differences in measurements within groups over time, were assessed using Signed 
Rank tests.  When the initial measurement was significantly associated with a change in 
measurement, model adjusted change in measurement means were calculated for three 
different values of initial measurement: the 10th percentile, mean, and 90th 
percentile.  Significant main effects of variables with more than two levels were further assessed 




comparison. P-values less than 0.05 were considered to be statistically significant.  All analyses 
were performed using SAS software version 9.4 (SAS Institute Inc., Cary, NC). 
To determine the reliability of interproximal bone height measurements, replicate 
measurements were made for five patients (40 sites), by the same rater (EJ); replicates were 
measured for two areas (treatment site and adjacent site), at baseline and final time 
points.  Replicate measurements were made 1 week apart.  Single measure intraclass 
correlations (ICCs) for absolute agreement were calculated using two-way mixed effects models 







Examiner calibration:  
The data collection examiners (AK, JP, RR) were calibrated for inter-examiner reliability 
and reproducibility using 48 randomly chosen sites. PD and CAL was reproducible at ± 1 mm for 
least 85% of sites (AK-RR = 88, 92%; AK-JP = 92, 90%; RR-JP = 94, 96%).  Intra-examiner reliability 
and reproducibility for interproximal bone height measurements (collected by EJ) were 
performed using 40 sites. Intraclass correlations were used for a two-way mixed model 
assessing absolute agreement - single measurement (ICC = 0.95325). 
Patient characteristics:  
All 50 patients who were eligible and invited to participate in the study agreed to do so. 
Two patients were unable to complete the study (4% dropout rate). One patient passed away 
before the six month periodontal maintenance appointment.  The second patient was 
eliminated from the study due to extraction of the experimental tooth before the six month 
periodontal maintenance appointment.  Both reasons for patient dropout were not believed to 
be related to any dental therapy provided during the study.  Forty-eight patients completed the 
study.  All study patients were asked at two weeks, six weeks, three months, six months, nine 
months, and 12 months post-therapy if any symptoms or problems were experienced.  Very few 
postoperative complications were encountered or reported throughout the study.  At two 
weeks, seven patients reported sensitivity to cold, three reported increased food impaction at 
the treatment site, and four reported slight pain requiring them to take acetominophen for two 




age of the patients was 67 (EMD) and 65 (Saline); there was no significant difference between 
ages of the patients in the two groups (p=0.41).  Patient characteristics at the baseline 
examination are displayed in Table 1.  
Clinical outcomes:  
The mean baseline and 12 month post-treatment results for respective changes in 
clinical outcomes between groups over time are reported in Tables 2-7.  As outlined in Table 2, 
no differences were found in PD (p=0.14) or CAL (p=0.58), at baseline between groups.  Both the 
PR/RP+EMD and PR/RP+S groups saw a reduction in PD (-2.29 ± 0.21 mm, p<0.0001; -2.39 ± 0.21 
mm, p<.0001) and gain in CAL (1.75 ± 0.30 mm, p<0.0001; 2.20 ± 0.30 mm, p<0.0001), from 
baseline to 12 months at the treatment site, with no significant differences between groups (PD: 
p=0.716; CAL: p=0.260).    
As summarized in Table 3, sites adjacent to the treatment sites saw smaller, but 
significant improvements in PD and CAL, with no significant differences between the groups (PD: 
p=0.799; CAL: p=0.743).  The adjacent sites showed a PD reduction of 0.89 ± 0.16 mm, p<.0001 
and gain in CAL of 0.66 ± 0.18 mm, p=0.001 in the PR/RP+EMD group and a PD reduction of 0.84 
± 0.16 mm, p<0.0001 and CAL gain of 0.59 ± 0.18 mm, p=0.002 in the PR/RP+S group over 12 
months.   
In Table 4, the direct buccal and lingual sites of the experimental teeth saw small, but 
statistically significant improvements for both groups in PD (PR/RP+EMD -0.44 mm ± 0.08 mm, 
p<0.0001; PR/RP+S -0.30 mm ± 0.08 mm, p=0.001) and a significant improvement in CAL in the 




PR/RP+S  0.50 mm ± 0.13 mm, p<0.001); however, the differences between the groups were not 
significant (PD: p=0.198; CAL: p=0.144).  
Interproximal sites opposite that of the treatment site (Table 5) also had a small, but 
significant improvement in PD (PR/RP+EMD -0.61 mm ± 0.11 mm, p<0.0001; PR/RP+S -0.48 mm 
± 0.11 mm, p<0.0001) and CAL (PR/RP+EMD -0.59 mm ± 0.14 mm, p<0.0001; PR/RP+S -0.57 mm 
± 0.13 mm, p<0.001) for both groups, with no significant differences between groups (PD: 
p=0.346; CAL: p=0.905).  Opposite sites were defined as the opposite interproximal surface on 
the treatment tooth, i.e., if the treatment site was the mesial surface, the distal surface of that 
same tooth would be considered the opposite site. 
No significant differences were found in IBH between groups at baseline for the 
treatment site (p=1.0) or the adjacent site (p=0.53).  Both groups had stable IBH (Table 6) at the 
treatment site over 12 months (PR/RP+EMD -0.20 ± 0.18 mm, p=0.28; PR/RP+S -0.33 ± 0.18 mm, 
p=0.08), with no significant differences between the groups (p=0.61).  Adjacent site bone 
heights also remained stable over the 12 month period in both groups (PR/RP+EMD -0.04 ± 0.16 
mm, p=0.81; PR/RP+S -0.18 ± 0.18 mm, p=0.26), with no significant difference found between 
the groups (p=0.51). 
Plaque index (Table 7) was calculated using 12 sites from the experimental teeth.  Both 
PR/RP+EMD and PR/RP+S groups saw a reduction in the experimental teeth plaque index 
(PR/RP+EMD -23% ± 5%, p=0.0001; PR/RP+S -12% ± 5%, p=0.028), with no significant differences 
between the two groups (p=0.129).  At the treatment site, the proportion of Emdogain patients 




baseline (87.5%).  For saline patients, the proportion of patients with plaque at twelve months 
(66.7%), did not significantly differ (p = 0.10), from the proportion at baseline (87.5%), as 





TABLE 1: Differences in Demographics between Groups (Data used for 
randomization)    
Statistic: Chi-Square       
        
   Emdogain Control    
    n % n % P-Value  
Gender           0.40  
  Female 13 54.2 11 42.3    
  Male 11 45.8 15 57.7    
Smoking Status           0.33  
  Non-smoker 21 87.5 20 76.9    
  Smoker 3 12.5 6 23.1    
Mean Age  66.92 (±1.15) 64.96 (±2.06) 0.41                  
*Indicates change was significant (p < 0.05) 
Interpretation: The distribution of men and women, or smoker and non-smokers, and age 







Table 2:  Clinical Outcomes at Treatment Site  
















































































*Indicates change was significant (p < 0.05) 
**Negative number indicates postoperative improvement 
Interpretation:  After controlling for the initial measurement and side with deepest pocket, 
significant changes were noted in both the EMD and saline groups for PD and CAL at the 









Table 3: Clinical Outcomes at Adjacent Site  

















































































*Indicates change was significant (p < 0.05) 
**Negative number indicates postoperative improvement 
Interpretation:  After controlling for the initial measurement and side with deepest pocket, 
significant changes were noted in both the EMD and saline groups for PD and CAL at the 
interproximal site adjacent to the treatment site.  There were no significant differences in the 









Table 4:  Clinical Outcomes at Direct Buccal and Lingual Sites 

















































































*Indicates change was significant (p < 0.05) 
**Negative number indicates postoperative improvement 
Interpretation:  After controlling for the initial measurement and side with deepest pocket, 
significant reductions were noted in both the EMD and saline groups for PD on the direct buccal 
and lingual of the treatment tooth.  A significant change in CAL was found in the saline group, 
but not the EMD group.  There were no significant differences in the changes observed between 










Table 5:  Clinical Outcomes at Opposite Sites 

















































































*Indicates change was significant (p < 0.05) 
**Negative number indicates postoperative improvement 
Interpretation:  After controlling for the initial measurement and side with deepest pocket, 
significant changes were noted in both the EMD and saline groups for PD and CAL at the site 
opposite of the treatment site on the treatment tooth.  There were no significant differences in 









Table 6: Interproximal Bone Height Outcomes 






















































































*Indicates change was significant (p < 0.05) 
**Negative number indicates postoperative improvement 
Interpretation:  No significant changes were seen in IBH in the EMD or saline groups at either 
the treatment site or the adjacent site, from baseline to 12 months.  No significant differences 








































































*indicates change was significant (p < 0.05) 
**Negative number indicates postoperative improvement 
Interpretation:  Data for experimental teeth plaque index was computed using the mean of six 
sites from the treatment tooth and six sites from the adjacent tooth, for a total of 12 sites.  
Significant reductions were seen in the plaque indices in both the EMD and saline control groups 
from baseline to 12 months, with no significant differences in the changes observed between 





Table 8: Change in Percent of Plaque at Treatment Site 
Statistics:  McNemar’s Test and Chi-Square 
 Baseline Post-Treatment p-Value 
EMD 87.5% 58.5% 0.02* 
Saline Control 87.5% 66.7% 0.10 
*indicates change was significant (p < 0.05) 
Interpretation:  For EMD patients, the proportion of patients with plaque at twelve months was 
significantly lower than the proportion at baseline (p = 0.02).  For saline patients, the proportion 
of patients with plaque at twelve months did not significantly differ from the proportion at 






CHAPTER 7:  DISCUSSION  
This double-blinded, randomized, controlled clinical trial compared clinical outcomes of 
two therapies, PR/RP+EMD (test) and PR/RP+S (control), in 6-9 mm pockets with a history of 
BOP in periodontal maintenance patients over a 12 month period.  Every precaution was taken 
to eliminate any bias by compartmentalizing the various aspects of this study protocol as 
follows:  masked examiners (AK, RR, JP) collected all data, patients were masked to treatment 
group assignment, treatment was performed by one of two clinicians (EJ, JG) with the assistance 
of the same dental hygienist (MC), one dental hygienist performed all maintenance procedures 
(MC), and randomization was done after PR/RP was completed to minimize any bias in 
thoroughness of debridement.  All of the participants in this study were on a three month 
periodontal maintenance recall program and had previously received regular PMT.  There were 
no significant differences in the baseline clinical measurements between the PR/RP+EMD and 
PR/RP+S sites. The manufacturer of Emdogain did not support the study in any way. 
The primary outcome measure in this study was a change in CAL, with change in IBH, PD, 
and PL as secondary outcome measures.  The current study demonstrated that inflamed, 6-9 
mm pockets, treated with PR/RP+EMD or PR/RP+S showed gain in CAL, PD reduction, and 
stability of IBH 12 months post-therapy in a periodontal maintenance population.  No significant 
differences were found between the groups when comparing clinical measurements of 
PR/RP+EMD to PR/RP+S at baseline or 12 months. To our knowledge, no other studies have 





The current study showed a significant gain in CAL in both the experimental and control 
groups.  The PR/RP+EMD group showed a gain of 1.75 ± 0.3 mm and the PR/RP+S group showed 
a gain of 2.2 ± 0.3 mm over 12 months.  The difference between the groups was not statistically 
significant (p=0.260).  The improvements seen in CAL in this study are slightly better than those 
reported in previous studies during initial therapy, with reported gains of 1.29 mm in PD >7 mm 
(Cobb, 1996).   
Patients who are not enrolled in regular PMT experience a significant amount of alveolar 
bone loss compared to those who receive regular PMT (Becker et al., 1984).  Previous studies 
have indicated patients who receive regular PMT, average less than 1mm of alveolar bone 
height changes over a 14 year period (Lindhe and Nyman, 1984).  These numbers are in line with 
changes in alveolar bone height found in this study.  The mean changes of approximately 0.2 to 
0.3 mm of alveolar bone height changes seen in the current study are short of the 1mm change 
in bone height needed for reproducibility when evaluating a series of radiographs (Hausmann et 
al., 1997).  Results from the present study indicate stable alveolar bone height in both groups at 
12 months, with no significant differences between the groups (p=0.61).  This is presumably due 
to the study population having been enrolled in a PMT program. 
The improvements seen in PD over the course of the study were similar to the 2.16 mm 
PD reduction reported by Cobb (1996), in pocket depths >7 mm following SRP.  In the current 
study, a PD reduction of 2.29 ± 0.21 mm, p<0.0001 was seen in the PR/RP+EMD group and a 
reduction of 2.39 ± 0.21 mm, p<.0001 in the PR/RP+S group.  These results indicated that the 




not provide an enhanced PD reduction.  These results are in line with those found by Gutierrez 
et, al., (2003) comparing the addition of EMD to SRP with SRP alone.  That study reported a PD 
reduction of 2.3 ± 0.5 mm in the control (SRP) sites and 2.0 ± 0.3 mm in the experimental 
(SRP+EMD) sites, with no significant differences between the groups (p>0.4). The conclusion 
from that study, similar to the conclusion of the current study, did not support the use of EMD 
during routine root planing. 
Plaque control was poor in the recruited maintenance patients for the current study.  
Plaque was present at a majority of treatment sites at both baseline (87%) and 12 month 
(PR/RP+EMD 58.3%; PR/RP+S 66.7%) post-therapy exam.  Although the improvements in PL 
were significant for both groups, only a small improvement in PL was seen over the course of 
the study.  The high supragingival plaque levels reported in the current study were similar to 
those found by Reinhardt et al. (2007), who showed 56%-68% explorer-detectable plaque levels 
across time points throughout a study evaluating posterior interproximal sites and the use of 
systemic sub-antimicrobial dose doxycycline.  All of the studied treatment sites were posterior, 
interproximal sites which have been shown to be difficult for patients to clean effectively 
(Cumming & Loe, 1973; Sherman et al., 1990; Prasad et al., 2011).  Improved PL levels may have 
resulted in better clinical results in the current study for both groups.  OHI was reviewed at 
every appointment; however, the EMD protocol requiring no brushing or interproximal cleaning 
of the treatment site for six weeks may have given the patients the impression they could do 
harm by cleaning the site, even once it was allowed.  Results from previous studies have 
indicated the stability of results gained following regenerative periodontal therapy are 




et al., 2005).  A plaque index <35% is recommended for periodontal stability (Purschwitz et al., 
2008), as renewed accumulation of plaque in the operated areas may result in recurrence of 
periodontal disease including a significant further loss of attachment (Nyman et al., 1977).  In 
addition, any explorer-detectable plaque was registered as positive in the current index, 
potentially overestimating of plaque levels compared to other studies. 
Many of the current studies evaluating the use of EMD were done utilizing surgical 
access.  Most of these studies showed a significantly greater improvement in clinical parameters 
with the use of EMD (Heijl et al., 1997; Pontoriero et al., 1999; Froum et al., 2001).  The study by 
Heijl et al. (1997), compared the long-term effects of EMD as an adjunct to MWF and 
demonstrated PD reduction of 3.1 mm in the EMD group and 2.3 mm in the placebo group at 36 
months (p<0.001); and gains in CAL of 2.2 mm with EMD and gains of 1.7 mm for placebo at 36 
months (p<0.01).  Pontoriero et al. (1999), reported a 4.4 mm reduction in PDs in sites treated 
with open flap debridement (OFD) + EMD compared to a 3.5 mm reduction in OFD alone 
(p<0.001); and a 3 mm improvement in attachment level with the addition of EMD, compared to 
1.8 mm gain with OFD alone (p<0.001).  Froum (2001), also compared OFD + EMD to OFD alone 
and showed a statistically significant difference in gain of attachment (1.5 mm) in favor of the 
addition of EMD.  These improvements are better than those found in the current study.  
Surgical access allows for a more thorough debridement of the root surface and less residual 
calculus than a closed, non-surgical approach (Caffesse et al., 1986).  Surgical access also allows 
for an environment with reduced blood, moisture, and debris, which may ensure the root 
surface is adequately coated with the EMD (Gutierrez et al., 2003).  When EMD is applied in a 




cannot be guaranteed (Gutierrez et al., 2003).  In fact, some studies have shown approximately 
50% of a medicament (chlorhexidine and stannous fluoride gels) applied subgingivally may be 
flushed out of a pocket immediately after insertion (Oosterwaal et al., 1990).  This high 
clearance rate may affect the amount of EMD which was able to remain in contact with the root 
surface in order to see a benefit.  Maintenance of a dry, bloodless field during EMD application 
is recommended by the manufacturer to achieve the best results.  These conditions were hard 
to achieve in the current study as the use of a localized papilla reflection did not allow for 
complete isolation of the experimental site.  This may explain the differences in the clinical 
outcomes reported by the current study, compared to those reported in studies with more 
extensive surgical techniques than described above.  Alternatively, the use of the endoscope 
may have improved the root debridement sufficiently to where EMD could not provide further 
impact. 
In contrast to the current study, some studies utilizing a similar minimally invasive 
surgical technique with papilla reflection and EMD application showed significant reductions in 
clinical parameters with the use of EMD (Harrel et al, 2005; Cortellini & Tonetti, 2007; Cortellini 
et al., 2008).  However, these results must be interpreted with caution as these studies were 
performed without a control.  In a study by Harrel et al. (2005), surgical treatment was 
performed using a minimally invasive technique and the addition of EMD in 160 sites.  Mean PD 
reductions (p=0.002) and CAL improvements (p=0.012) were significantly greater than 3 mm, 
with mean post-surgical PDs of 3.17 mm and attachment levels of 4.05 mm.  A study by 
Cortellini & Tonetti (2007), utilized a minimally invasive, papilla preservation, surgical technique 




surfaces in 13 infrabony pockets.  The one year CAL gain was 4.8 ± 1.9 mm.  Residual PDs were 
2.9 ± 0.8 mm. Differences between baseline and one year CAL and PD were both clinically and 
statistically significant (p<0.0001).  The one year percent resolution of the defect was 88.7 ± 
20.7%, and reached 100% of the baseline intra-bony component in seven sites.  In a follow-up 
study, a similar protocol was used on a larger sample size (44) and showed similar 
improvements.  The one year CAL gain was 4.4 ±1.4 mm (p<0.0001 compared with baseline). 
Seventy-three per cent of defects showed CAL improvements ≥4 mm.  This corresponded to an 
83 ± 20% resolution of the defect (15 defects were completely filled).  Residual PDs were 2.5 ± 
0.6 mm (Cortellini et al., 2008).  The major difference between the current study and the 
Cortellini & Tonetti (2007) and Cortellini et al., (2008), studies were the site characteristics.  The 
current study evaluated the effect of EMD with a papilla reflection technique in sites with 
primarily horizontal bone loss, as confirmed by only a 0.4 mm mean difference in IBH between 
treatment and adjacent sites (Table 6), with intervention being performed during a periodontal 
maintenance appointment, whereas the two previously mentioned studies evaluated infrabony 
defects during dedicated and more extensive surgery appointments.  This may play a factor in 
the amount of regeneration which occurred, as defects with a depth of >3 mm and a 
radiographic defect angle of 25 degrees were reported to be the most amenable to regenerative 
procedures (Tonetti et al., 2003).  Non-supportive anatomy, defined as predominantly a one 
wall defect, is a risk factor for failure of regeneration attempts (Cosyn et al., 2012).  The study by 
Harrel (2005), was performed at multiple practices and the mean results were presented.  The 
data from this study may have been skewed, as one practice combined EMD with freeze-dried 




Harrel study was also funded by Straumann, the manufacturer of EMD.  The current study added 
30 minutes of the PMT appointment, which patients tended to accept more readily than a 
separate “surgery” visit.  Outcomes resulted in mean probing depths around 4mm with access 
for interproximal brushes, and very low patient morbidity (most patients reported no use of 
analgesics postoperatively). 
Improvements in clinical outcomes (PD and CAL) were seen in the current study at sites 
other than the treatment site (adjacent, direct buccal and lingual, and opposite).  Most of these 
improvements were small (<1 mm).  While these were statistically significant, the clinical 
ramifications are minimal and well within measurement error of ± 1 mm (Osborn et al, 1992; 
Corrainin et al., 2013).  These improvements may also be contributed to the Hawthorne Effect, 
and the patients’ improvement in homecare due to knowledge of participating in a clinical 
study. 
This study has several limitations. Patients were observed for a period of only 12 
months and a longer duration would be ideal to determine long term stability.  Also, the history 
of each study site was not investigated, some may have been experiencing active attachment 
loss while others may have been periodontally stable. This may have influenced the response to 
the treatment and the inflammatory condition of the pockets.  Although a control was used in 
this study, both treatment modalities incorporated the use of the endoscope.  The enhanced 
visualization provided by the endoscope may have reduced the effect which would have been 




However, with clinical improvements seen in both groups, this may indicate thorough root 
debridement is a more important factor than the addition of EMD. 
Many adjunctive therapies (local chemotherapeutics, lasers, biologics, etc.) are being 
used to try to enhance the clinical benefits encountered with both non-surgical and surgical 
periodontal therapies.  More research is needed to determine the clinical benefits, as well as the 
cost benefit of these adjunctive therapies.  The American Academy of Periodontology (AAP) 
stated that the use of adjuncts is not proven to “reduce the need for surgery or improve long-
term tooth retention,” or to be cost effective (AAP Statement 2006). The AAP addressed the 
limitations of adjunctive therapies and stated that local adjuncts resulted in modest 
improvements (PD reduction of 0.25-0.5 mm) in the clinical outcomes of pockets ≥ 5 mm.  Much 
of the research surrounding EMD as an adjunct to periodontal debridement/surgery is 
conflicting, has been sponsored by the manufacturer, or lacks controls.  Additional research is 
needed to determine the clinical benefits of EMD, its regenerative ability, and how to best 
implement the use of EMD to enhance the treatment of periodontitis.  Further research is also 
needed to determine EMD’s effect on inflammatory biomarkers, the reduction of the 
subgingival bacterial flora, and how these correlate with an improvement in the clinical 






CHAPTER 8:  CONCLUSION  
Scaling and root planing with papilla reflection in inflamed, persistent, deep periodontal 
pockets during PMT with or without the addition of Emdogain, resulted in improvements in PD, 
and CAL, with stable IBH after 12 months of PMT.  The addition of EMD does not enhance the 
clinical benefits of PR/RP in the treatment of periodontal maintenance patients with inflamed 6-
9 mm probing depths.  
Due to the amount of conflicting data regarding the use of EMD, further studies 
comparing PR/RP+EMD to other adjunctive therapies should be pursued.  Additionally, future 
research could be done to assess the anti-microbial and anti-inflammatory effects of EMD in 
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Appendix B:  Raw Clinical Data 













N1 2 59 1 1 7 6 4 
N2 1 67 2 0 6 6 5 
N3 1 74 1 0 9 5 3 
N4 2 70 2 0 4 7 3 
N5 1 67 2 0 7 5 3 
N6 1 76 1 1 4 6 4 
N7 2 55 1 0 6 7 4 
N8 2 63 2 0 5 7 3 
N9 2 80 2 0 5 6 4 
N10 1 69 1 0 6 8 3 
N11 1 62 1 0 7 8 4 
N12 2 67 1 0 7 7 3 
N13 2 76 2 0 6 5 4 
N14 1 58 2 1 5 8 3 
N15 2 83 2 0 4 6 8 
N16 1 68 2 0 5 6 6 
N17 2 47 1 0 6 5 5 
N18 2 44 1 1 5 6 4 
N19 2 65 1 1 4 6 3 
N20 1 67 1 0 4 9 3 
N21 1 59 2 0 8 7 5 
N22 1 65 1 0 4 6 3 
N23 1 80 2 0 3 6 3 
N24 2 62 1 1 6 6 6 
N25 1 65 2 0 4 6 3 
N26 1 62 1 0 7 9 4 
N27 1 67 2 1 6 4 3 
N28 2 75 2 0 5 6 3 
N29 2 76 1 0 6 5 5 
N30 1 62 2 0 6 6 3 
N31 2 68 1 0 6 7 6 
N32 2 69 1 1 5 6 2 
N33 2 66 1 1 6 7 5 




N35 2 60 1 0 5 6 4 
N36 1 69 2 0 3 6 5 
N37 2 79 1 0 5 7 5 
N38 1 69 1 0 5 6 5 
N39 2 65 2 0 6 6 3 
N40 2 73 1 0 6 6 4 
N41 2 67 2 0 6 6 4 
N42 2 73 2 0 4 6 4 
N43 1 68 2 0 6 7 6 
N44 2 78 1 0 4 6 4 
N45 2 48 2 0 5 6 4 
N46 1 58 1 0 6 4 5 
N47 1 61 2 0 6 6 6 
N48 1 75 1 0 8 6 2 
N49 1 68 1 0 4 6 4 
N50 1 70 2 0 5 6 4         
 
1 - EMD 
 
1 - male 0 - non-
smoker 
   
 
2 - saline 
 
2 - female 1 - smoker 



































N1 4 2.5 3 4.5 6.5 1 
N2 6 2.5 2.5 3.5 4 0 
N3 3 2 2 4.5 2.5 0 
N4 4 3 3 3.5 3.5 2 
N5 3 3 2 4 3 1 
N6 4 4 2.5 4 4 0 
N7 4 3 2 3 4 0 
N8 5 2.5 2 4 4 0 
N9 6 2.5 2.5 2.5 4 0 
N10 6 3.5 3.5 5 7 0 
N11 4 2.5 2.5 4 3.5 0 
N12 3 2.5 2 2.5 3 3 
N13 4 2 2.5 2 3 0 
N14 3 2 2 5 3.5 0 
N15 4 2.5 2.5 3 3 0 
N16 6 2 4 3 3 4 
N17 6 3 2.5 6 4.5 2 
N18 6 2 2.5 3 2.5 1 
N19 3 3 2 5.5 3 0 
N20 5 5 2 3.5 3 1 
N21 5 2 2 2 2.5 2 
N22 3 2 2.5 3 3 0 
N23 3 2.5 2 3 3 0 
N24 8 2.5 2.5 5.5 5.5 0 
N25 4 3.5 2 4 3 0 
N26 6 2.5 3 6 3.5 0 
N27 2 2 2 2.5 3 2 
N28 5 2 2 3.5 3.5 1 
N29 3 2.5 3 3 3 1 
N30 3 2 2.5 5 4.5 2 
N31 7 4.5 3 4 3.5 0 
N32 3 4 2 2 4 3 
N33 6 3.5 3.5 4 3.5 0 
N34 6 3 3 3 7 0 
N35 4 2 2 3.5 4.5 0 




N37 5 3.5 2 4 4 0 
N38 6 3 2.5 4 3.5 0 
N39 4 2 1.5 6 3 3 
N40 4 2.5 2.5 4 4 0 
N41 7 2.5 3 4 9 2 
N42 4 2 2.5 4.5 3 0 
N43 7 3 2.5 6.5 4.5 0 
N44 4 3 3 4 3 0 
N45 5 3 3.5 4 4 1 
N46 4 2.5 3 3 7 2 
N47 6 2 2 3.5 4 1 
N48 4 3 2.5 3.5 2.5 0 
N49 6 5.5 3.5 3.5 2.5 2 







































N1 2 2.5 2.5 5 1 1.5 
N2 0 0 1 0.5 0 0 
N3 0 0 0 0 1.5 0 
N4 3 0 3 2 2 0 
N5 0 0.5 0 1.5 0 0 
N6 0 0 0.5 0.5 0 0 
N7 0 0 0 0 0 0 
N8 0 0.5 2.5 0.5 1 0 
N9 0 1.5 0.5 0 0.5 0 
N10 0 0 0 0.5 0 0 
N11 0 0 0 1 0 0 
N12 2 1 2.5 1 1.5 0.5 
N13 0 0.5 1.5 1 1.5 0 
N14 0 0 0 0 0 0 
N15 0 0 0 0 0 0 
N16 3 2 2.5 4.5 2 4 
N17 2 2 2 3 1 2.5 
N18 0 0.5 1 0 0 0 
N19 0 0 0.5 0 0 0 
N20 2 1.5 1.5 1 0.5 0 
N21 2 2.5 3 5 3.5 6 
N22 0 1 0.5 0.5 0 0 
N23 0 0 1 0 2.5 0 
N24 0 0 1.5 2 0 0 
N25 1 1.5 0.5 1 0 1 
N26 0 0 1 0 0 0 
N27 2 0 2.5 2.5 0.5 1.5 
N28 1 0 1 1 0 0.5 
N29 0 0 1.5 1.5 2 1 
N30 1 0 3 0.5 2 0 
N31 0 0 0 0.5 0 0.5 
N32 5 3 3.5 3 2..5 2.5 
N33 0 0 0.5 1.5 0 0 




N35 0 0 1 0 0.5 0 
N36 2 3 1 5 2 3 
N37 0 0 1.5 0 0 0 
N38 0 0 0.5 0 0 0 
N39 3 2.5 4 2.5 4 1.5 
N40 0 0 0 1 0 0 
N41 0 0 2 0 0.5 0 
N42 0 0 0.5 0.5 0 0 
N43 0 0 2.5 0 0 0 
N44 0 0 0.5 0 0 0 
N45 1 0.5 1.5 0 0.5 0 
N46 0 2.5 1.5 1.5 1 1 
N47 0 0 0.5 1 0 1 
N48 0 0 0.5 0 0 0 
N49 0 0 0.5 1 0 0.5 






























N1 1 1 5.4 8.09 18 0.75 
N2 0 0 4.58 4.41 26 0 
N3 1 1 4.53 2.48 23 0.83 
N4 0 1 4.34 1.38 26 0.75 
N5 1 0 3.15 3.11 28 0.916 
N6 0 0 7.83 5.17 19 0.167 
N7 1 1 6.45 3.56 23 1 
N8 1 1 4.67 4.66 26 0.83 
N9 1 0 6.09 6.59 26 0.416 
N10 1 1 4.31 2.86 26 0.5 
N11 1 1 8.46 7.6 26 0.75 
N12 0 1 6.28 3.83 20 0.416 
N13 1 1 1.22 3.35 22 1 
N14 0 1 5.59 5.73 27 0.33 
N15 1 1 6.34 4.91 18 0.83 
N16 1 1 7.37 8.9 27 0.916 
N17 1 1 8.11 7.34 24 0.916 
N18 1 1 5.94 6.2 28 0.58 
N19 1 1 4.96 4.41 25 0.5 
N20 1 1 6.94 6.91 21 1 
N21 0 0 5.84 8.61 14 0 
N22 1 1 3.47 3.57 12 0.416 
N23 0 1 4.47 3.1 27 0.33 
N24 0 0 7.87 8.62 22 0.167 
N25 0 1 3.19 1.93 22 0.5 
N26 0 1 5.44 3.19 25 0.58 
N27 1 1 8.6 5.61 25 1 
N28 0 1 4.6 4.54 25 0.5 
N29 0 0 4.42 4.48 25 0.167 
N30 1 0 3.94 3.53 25 0.58 
N31 0 1 2.86 3.92 24 0.5 
N32 0 1 3.83 7.25 23 0.5 
N33 1 1 6.17 5.82 28 0.58 
N34 1 1 8.75 5.01 25 0.83 
N35 1 1 4.72 3.11 28 0.58 




N37 1 1 3.23 2.83 32 1 
N38 1 1 2.2 3.64 32 1 
N39 0 1 4.38 6.36 28 0.416 
N40 1 1 1.93 2.96 25 1 
N41 0 1 5.7 6.05 29 0.67 
N42 1 1 3.85 2.47 29 1 
N43 1 1 5.97 1.67 23 1 
N44 1 1 3.26 2.94 20 1 
N45 1 1 6.5 4.12 23 1 
N46 1 1 5.61 4.17 12 1 
N47 1 1 3.15 3.5 26 0.67 
N48 1 1 5.91 7.31 24 0.83 
N49 1 1 3.23 3.3 27 0.83 
N50 1 1 3.94 1.85 25 0.75        
 
0 - no 
plaque 
0  - no 
plaque 
    
 
1 - plaque 1 - plaque 

































N1 5 5 3.5 2.5 2.5 3.5 
N2 4 5 3.5 1.5 1.5 3 
N3 5 4 3 3 2.5 3 
N4 4 4 3.5 2.5 2 3 
N5 4 4 2.5 2 1.5 3 
N6 3 3 3.5 3 2.5 3 
N7 4 3 3 2 2 3.5 
N8 5 5 3.5 2.5 2.5 3.5 
N9 5 7 5 2.5 3.5 3 
N10 4 5 4 3 3 4.5 
N11 4 5 3 2 2 3 
N12 6 6 3 2 2 3 
N13 3 3 3 2 2 2 
N14 4 5 3.5 2.5 2 4.5 
N15 
      
N16 5 5 6 2 4 2.5 
N17 3 3 4 3 2 3 
N18 3 4 3.5 2 2 3 
N19 3 3 4 3 2 3.5 
N20 4 5 3 2 2 3 
N21 4 3 3 2 1.5 3 
N22 4 6 6 2.5 2.5 2.5 
N23 3 4 2.5 2 2 2.5 
N24 5 6 4.5 2.5 2 4 
N25 4 5 4 3.5 2 3 
N26 4 6 3.5 2.5 2.5 4 
N27 3 3 2 1 1 2 
N28 3 4 3 2.5 2.5 3.5 
N29 3 3 3 2 2.5 4 
N30 5 4 3 2.5 2.5 4.5 
N31 5 5 5 4 2.5 3.5 
N32 3 4 3 3.5 2 2.5 
N33 3 6 5 3 3 5 
N34 3 3 4 2 2 3 
N35 5 5 4 2 2 5 




N37 3 5 3.5 2.5 2.5 3 
N38 5 5 4.5 2.5 2.5 4 
N39 3 5 3 2 2.5 3 
N40 3 5 2 2 2 3 
N41 4 4 4.5 2 2.5 2.5 
N42 4 4 4 2 2.5 4 
N43 4 4 4 2 2 3.5 
N44 
      
N45 5 4 4 3 3 3.5 
N46 3 4 3.5 2 2 2.5 
N47 4 4 4.5 2 2.5 3 
N48 5 5 3 2.5 2 3 
N49 3 5 4 3.5 2.5 3 

































N1 4.5 2 2 3 1.5 3.5 
N2 2.5 0 0 0 0.5 0 
N3 3 1 0 0 0.5 0 
N4 3.5 2 2 0 2.5 1.5 
N5 2 2 0 1.5 0.5 1.5 
N6 3.5 0 0 1 1 1 
N7 3.5 0 0 0 0 0 
N8 2.5 0 0 0 2 0 
N9 3.5 1 0 0.5 0 0 
N10 5 1 0 0.5 0 0.5 
N11 3 0 0 0 0 0.5 
N12 3.5 2 3 2 2 1 
N13 2.5 0 0 0 1 0 
N14 3 0 0 0 0.5 0 
N15 
      
N16 5 3 5 2..5 3 5 
N17 4 1 1 0.5 1 2.5 
N18 2 0 0 1 0.5 0 
N19 4 1 0 0.5 1 0.5 
N20 2.5 3 2 2 2.5 1 
N21 2.5 3 2 3 3.5 5 
N22 3.5 0 0 0 1 0.5 
N23 2.5 0 1 0.5 2 1 
N24 5.5 0 0 1.5 1 1.5 
N25 2.5 0 1 0.5 0.5 1 
N26 3.5 2 1 0 1 0 
N27 3 4 2 0.5 3 3 
N28 3 2 2 0 1 0 
N29 3.5 1 0 1 1 1.5 
N30 3.5 2 1 0 2 0 
N31 3.5 0 0 0.5 0.5 1.5 
N32 3.5 3 6 3 3.5 3 
N33 3.5 0 0 1 0 2 
N34 3.5 0 0 0.5 0.5 0 
N35 3.5 0 0 0 1 0 




N37 3.5 0 0 0 0.5 0 
N38 3.5 0 0 0 0.5 0.5 
N39 3.5 2 2 2 2.5 2.5 
N40 3 1 0 0.5 0.5 1.5 
N41 6 2 2 1 2 0.5 
N42 3.5 1 0 0 0.5 0.5 
N43 3 3 3 1 4 2.5 
N44 
      
N45 3.5 0 1 0 0.5 0 
N46 3 1 1 1 1.5 2 
N47 6 1 0 0.5 0.5 0.5 
N48 2.5 1 1 1 1 0 
N49 3.5 0 0 0 0 0.5 





































N1 0 1 1 1 6.75 8.54 
N2 0.5 0 1 1 4.24 3.03 
N3 0.5 0 0 0 4.38 2.56 
N4 1 0 0 0 5.45 2.1 
N5 0 0 0 0 3.25 3.11 
N6 0 0 1 0 6.83 6.58 
N7 0 0 0 1 5.26 4.45 
N8 0.5 0 1 1 4.56 4.04 
N9 0.5 0 1 1 6.44 6.12 
N10 0 0 1 1 4.2 2.68 
N11 0 0 1 0 7.33 6.49 
N12 2 1 1 1 6.76 4.48 
N13 0.5 0 0 1 1.88 3.09 
N14 0 0 0 0 5.75 5.61 
N15 
      
N16 2 1.5 1 1 7.43 8.51 
N17 0 1.5 1 1 6.27 6.4 
N18 0 0 1 1 4.4 4.56 
N19 0 0 1 1 5.04 4.62 
N20 0.5 0 0 0 4.5 6.22 
N21 2.5 3 0 0 5.08 8.57 
N22 0 0 0 1 4.44 3.96 
N23 2.5 0 0 0 4.68 3.47 
N24 0 0 1 1 6.34 8.63 
N25 1 0.5 0 1 4.41 2.37 
N26 0 0 1 1 5.14 4.04 
N27 1.5 3 0 0 7.7 5.14 
N28 0 0 1 1 3.8 3.58 
N29 0.5 1 0 1 4.14 4.4 
N30 1 0 1 1 4.27 4.1 
N31 0 1 0 0 2.58 3.13 
N32 2 2.5 1 1 3.34 6.57 
N33 0 0 1 1 6.04 5.99 
N34 0 0 0 0 4.46 3.39 




N36 2 2.5 1 1 5.2 6.87 
N37 0 0 0 1 1.97 1.92 
N38 0 0 1 1 3.21 3.67 
N39 4 0.5 1 1 6.07 6.4 
N40 0 2 0 0 2.11 2.81 
N41 1 0 0 0 4.77 5.72 
N42 0 1.5 1 1 3.76 2.92 
N43 3 1 1 1 6.07 2.78 
N44 
      
N45 0 0 1 1 6.67 5.13 
N46 0 2 1 1 5.48 3.06 
N47 0 0 1 1 2.63 1.65 
N48 0.5 0 1 1 5.55 7.81 
N49 0 0 0 1 2.48 2.35 
N50 0 0 0 0 3.35 3.1        
   
0 - no 
plaque 
0 - no 
plaque 
  
   





































N1 18 0.67 5.59 8.22 6.58 8.46 
N2 26 0.42 4.21 4.02 4.54 2.81 
N3 23 0.167 3.69 3.9 3.85 2.39 
N4 26 0.18 4.59 1.33 5.27 2.14 
N5 28 0.33 3.16 3.01 3.33 3.2 
N6 19 0.5 
    
N7 23 0.5 
    
N8 26 0.58 
    
N9 25 0.67 
    
N10 24 0.58 
    
N11 26 0.33 
    
N12 20 0.75 
    
N13 21 0.5 
    
N14 27 0 
    
N15 
      
N16 27 0.75 
    
N17 24 0.67 
    
N18 28 0.58 
    
N19 25 0.5 
    
N20 21 0.25 
    
N21 14 0 
    
N22 12 0.167 
    
N23 27 0.33 
    
N24 22 0.75 
    
N25 21 0.416 
    
N26 25 0.58 
    
N27 25 0 
    
N28 25 0.67 
    
N29 25 0.25 
    
N30 25 0.67 
    
N31 22 0.67 
    
N32 22 0.58 
    
N33 28 1 
    
N34 25 0.416 
    
N35 28 0.083 




N36 25 0.67 
    
N37 32 0.416 
    
N38 32 0.83 
    
N39 27 0.58 
    
N40 25 0.416 
    
N41 29 0.25 
    
N42 29 0.83 
    
N43 23 0.83 
    
N44 
      
N45 23 1 
    
N46 12 0.83 
    
N47 26 0.67 
    
N48 24 0.25 
    
N49 27 0.5 
    
N50 25 0.33 
    
 
